Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
Proc Natl Acad Sci U S A
; 119(45): e2206333119, 2022 11 08.
Article
in En
| MEDLINE
| ID: mdl-36322769
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Influenza Vaccines
/
Orthomyxoviridae Infections
/
Influenza, Human
/
Influenza A Virus, H1N1 Subtype
Limits:
Animals
/
Humans
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2022
Document type:
Article
Country of publication:
Estados Unidos